BULLFROG AI HOLDINGS, INC. Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense
BULLFROG AI HOLDINGS, INC. (BFRG) reported Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense of $191.77 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense · last filed 2024-08-07
- BULLFROG AI HOLDINGS, INC. deferred compensation arrangement with individual, allocated share-based compensation expense for the quarter ending 2024-06-30 was $191.77K, a 24.44% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. deferred compensation arrangement with individual, allocated share-based compensation expense for the quarter ending 2024-03-31 was $333.02K, a 216.44% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. deferred compensation arrangement with individual, allocated share-based compensation expense for the quarter ending 2023-09-30 was $116.41K, a 125.88% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. deferred compensation arrangement with individual, allocated share-based compensation expense for the quarter ending 2023-06-30 was $253.82K, a 56178.49% increase year-over-year.
| Period end | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense 3 month | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense 3 month as first filed | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense 6 month | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense 9 month |
|---|---|---|---|---|
| 2024-06-30 | $191.77K 10-Q · filed 2024-08-07 | $524.79K 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | $333.02K 10-Q · filed 2024-05-10 | |||
| 2023-09-30 | $116.41K 10-Q · filed 2023-11-14 | $370.23K derived: sum of 2 quarters · filed 2024-08-07 | $475.46K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $253.82K 10-Q · filed 2024-08-07 | $260.62K 10-Q · filed 2023-08-14 | $359.05K 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $105.24K 10-Q · filed 2024-05-10 | |||
| 2022-09-30 | $51.54K 10-Q · filed 2023-11-14 | $51.99K derived: sum of 2 quarters · filed 2023-11-14 | $290.88K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $451.00 10-Q · filed 2023-08-14 | $1.11K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |